BCTX — BriaCell Therapeutics Corp.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1610820 ·
Last close
$3.51
Market Cap
$30.65M
52W High
$13.09
52W Low
$2.60
ADV30
61,512
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jul 2026 0 — -12,579,234 -12,320,370 23,579,729 9,852,435 8,020,587
Apr 2026 0 — -7,620,794 -7,164,507 27,071,310 6,880,221 3,662,350
Jan 2026 0 — -7,531,266 -7,221,820 33,594,454 29,903,628 3,380,646
Oct 2025 0 — -8,322,943 -8,197,565 13,075,050 2,714,012 3,724,646

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-28,651,323
Investing CF
$-3,805,049
Financing CF
$31,814,999
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-24.34
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-146,659,826
Inventory
—
Receivables
$669,173
ST Investments
$10,688,277
EBIT TTM
$-35,574,649
Pretax Income TTM
$-35,325,292
Interest Exp TTM
$66,610
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jul 2026 0 -36,054,237 -34,904,262 23,579,729 8,020,587 16,400,887 -28,651,323
Jul 2025 — — — — — — —
Jul 2024 0 -33,330,076 -4,791,466 5,872,261 8,557,193 -2,382,410 -24,126,128
Jul 2023 0 -23,272,264 -20,302,394 27,163,577 30,940,758 -3,777,181 -23,744,860
Jul 2022 0 -15,285,553 -26,838,903 42,577,041 32,248,109 10,328,932 -12,484,376

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$27,071,310
Forward EPS
$-0.39

Peers — same industry

TickerNameMarket CapLastDaily %
NXTC NextCure, Inc. $30.68M $6.70 —
NSRX Nasus Pharma Ltd $30.57M $2.61 —
RNTX Rein Therapeutics, Inc. $30.75M $0.36 —
RLFTY MindMaze Therapeutics Holding SA $30.24M $0.18 —
TELO Telomir Pharmaceuticals, Inc. $31.17M $0.42 —

News headlines (Yahoo Finance, 1h cache)

BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
2026-11-06 14:00 · Yahoo
BriaCell Awarded 2026 “Immunotherapy Solution of the Year” By BioTech Breakthrough
2026-11-05 13:00 · Yahoo
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
2026-11-03 14:00 · Yahoo
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
2026-10-23 11:30 · Yahoo
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
2026-10-06 11:30 · Yahoo
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
2026-09-14 11:30 · Yahoo
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
2026-09-08 11:30 · Yahoo
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
2026-07-16 11:30 · Yahoo
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
2026-07-15 11:30 · Yahoo
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
2026-07-07 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.